KLAR stock news · Klaria Pharma
Get alerts for KLAR
Follow Klaria Pharma (KLAR) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for KLARKlaria Pharma says its Sumatriptan Alginate Film is approved in Europe and shares plans for a possible US launch.
Good for KLARKlaria says its migraine film is approved in key European countries, and its partner is preparing a launch. A US plan adds promise, though sales have not started.
Anticipation builds as Affirm's shares fluctuate before earnings report: Could it decline similarly to Klarna?
NeutralKlarna's recent weak earnings may set a comparative backdrop for Affirm's performance, influencing investor sentiment.
Following Q2 results, analysts downgrade their projections for Klarna Group.
NeutralKlarna Group's Q2 results exceeded earnings expectations but fell short on future sales guidance, prompting analysts to lower their price targets. This mixed performance has led to a bearish sentiment in the market, reflected in a slight decline in share price.
Klarna's shares attempt to recover following a 23% drop as German consumer sentiment dampens enthusiasm.
NeutralKlarna's stock has experienced a sharp decline following its earnings report, which revealed a weaker sales outlook for Germany, its largest market. Despite beating earnings expectations, the ongoing challenges in consumer spending are raising concerns among investors, leading to a significant selloff.
Klarna's Q2 2026 Earnings Call Complete Transcript Available.
NeutralKlarna's Q2 2026 earnings call revealed strong financial results with a 27% revenue increase and a positive net income of $9 million. The company also announced strategic partnerships that are expected to drive future growth, particularly in the US market, despite some challenges in the German consumer market.
Klarna warns of challenges for German consumers and revises its 2026 sales forecast downward.
Good for KLARKlarna's stock is trading lower following its second-quarter earnings report, which, despite beating estimates, included a disappointing sales outlook for 2026. This guidance cut raises concerns about future growth and profitability, particularly in the German market, which could impact investor sentiment negatively.
Upcoming earnings report from Klarna Group prompts top analysts to adjust their forecasts.
NeutralKlarna Group is set to release its earnings report, with analysts expecting a quarterly loss but also showing optimism through revised price targets. This could lead to increased trading activity as investors react to the anticipated results.
SEC files fraud charges against Adit Ventures, with CEO Eric Munson firmly denying the claims.
Bad for KLARAllegations of misrepresentation regarding Klarna shares could negatively impact investor trust and Klarna's market position.